by According to a research report “Clinical Nutrition Market (By Route of Administration: Oral, Enteral, and Parental; By Application: Cancer, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others; By End User: Pediatric, Adult, and Geriatric) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030″ published by Precedence Research, the clinical nutrition market is projected to grow from USD 38.43 billion in 2022 and is forecasted to reach USD 61.8 billion by 2030; it is expected to grow at a CAGR of 6.1 % from 2021 to 2030.
The study provides an analysis of the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2021 is considered as the base year.
A clinical nutrition is a sort of medicine that aids in the overall health of a patient. It aids in the improvement of the metabolic system by supplying sufficient supplements such as vitamins, minerals, and other nutrients. Clinical nutrition helps to avoid diet related disorders by diagnosing and treating diseases that impact the intake, intestinal absorption, and metabolism of dietary elements. Cardiac rehabilitation, diabetes, renal dialysis, cancer, wellness centers, and community-basedintervention programs are among the areas where it is used.
The rising prevalence of metabolic disorders, increasing healthcare spending, and the expansion of the middle class in emerging nations are all factors moving the clinical nutrition market forward. The metabolic disorders have become more common in recent years.
Get a Free Sample Copy of this Report with Global Industry Analysis @ https://www.precedenceresearch.com/sample/1527
Table of Contents
Scope of the Clinical Nutrition Market
| Report Coverage | Details |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
Market Estimations Y-O-Y:
- Market Size Was Valued In 2021: US$ 36.25 Billion
- Market Size Is Projected to Grow By 2022: US$ 38.43 Billion
- Market Size Is Projected to Grow By 2023: US$ 40.76 Billion
- Market Size Is Projected to Grow By 2024: US$ 43.23 Billion
- Market Size Is Projected to Grow By 2025: US$ 45.85 Billion
- Market Size Is Projected to Grow By 2026: US$ 48.65 Billion
- Market Size Is Projected to Grow By 2027: US$ 51.63 Billion
- Market Size Is Projected to Grow By 2028: US$ 54.8Billion
- Market Size Is Projected to Grow By 2029: US$ 58.17 Billion
- Market Size Is Projected to Grow By 2030: US$ 61.8 Billion
- Compound Annual Growth Rate (CAGR) from 2022 to 2030: 6.1 percent
Market Dynamics
Drivers
Surge in demand for probiotics and functional food products
The significant increase in the number of health-conscious consumers, combined with the rising demand for functional food and beverages, is expected to have a significant impact on the overall growth of the global clinical nutrition products market over the next decade. Because of the sheer size of the market and the consistent rise in the number of health-conscious consumers, the Asia Pacific region is likely to be one of the most lucrative markets for players operating in the current clinical nutrition products market landscape. Furthermore, the growing geriatric and elderly populations in developing countries are expected to drive up demand for clinical nutrition in the near future.
Restraints
Lack of consumer awareness
The people are unaware about the nutrition products. They lack knowledge about the different types of clinical nutrition for different types of age group people. The clinical nutrition products are available for the infants as well. Hence, the lack of awareness among consumers is a restricting factor for the growth of the clinical nutrition market during the forecast period.
Read Also: Automotive Thermal Systems Market Size, Share Statistics 2021-2030
Opportunities
Rising prevalence of chronic disorders
The growing number of people worldwide suffering from chronic diseases such as diabetes and cancer, combined with the significant growth in the geriatric population, will fuel the clinical nutrition market’s growth in the coming years. Because those suffering from chronic disorders have a deficiency in essential nutrients, the rise in chronic disorders has necessitated the use of clinical nutrition prescriptions. Furthermore, the growing obese population base as a result of poor eating habits and a lack of exercise can propel clinical nutrition market growth.
Elderly people frequently lose their appetites or have digestive problems, necessitating nutrient administration via enteral or parenteral routes. This factor is expected to benefit the global clinical nutrition market over the next few years. Furthermore, the significant increase in premature births, as well as the overall high birth rate around the world, may benefit the global market. Thus, the rising prevalence of chronic disorders is creating lucrative opportunities for the growth of the clinical nutrition market.
Challenges
Stringent government regulations
The stringent regulations and reimbursement issues are expected to stymie market growth. Clinical nutrition products are classified as pharmaceuticals.Thus, the major market players need to follow certain laws and guidelines set by Food and Drug Administration (FDA). As a result, the strict government regulatory frameworks are a major challenge for the growth of the clinical nutrition market during the forecast period.
Report Highlights
- Based on the route of administration, the oral segment dominated the global clinical nutrition market in 2020 with highest market share. As the enteral and parental segments are costly due to the cost of processing nutrients or goods, the oral segment has dominated the market. The oral category has the biggest market share, and this trend is projected to continue throughout the year. This increase can be linked to its widespread and consistent use among patients due to its ease of use and availability for a variety of ailments.
- Based on the end user, the pediatric segment is estimated to be the most opportunistic segment during the forecast period. The concerns regarding malnutrition in children are projected to be a prominent growth factor in the clinical nutrition market.
Regional Snapshot
North America is the largest segment for clinical nutrition market in terms of region. Fast food consumption contributes to chronic health problems due to the high levels of trans fats, saturated fats, and sodium in this diet. The hypertension, diabetes, and cardiovascular diseases are all linked to these ingredients.
Asia-Pacific region is the fastest growing region in the clinical nutrition market. The Asia-Pacific has a high prevalence of metabolic syndrome, which is characterized by anomalies such as obesity, hypertension, and raised blood glucose levels. The number of multimorbid patients is likewise increasing as people get older.
Some of the prominent players in the global clinical nutrition market include:
- Abbott Laboratories
- B. Braun Melsungen AG.
- Mead Johnson Nutrition Company
- Perrigo Company Plc.
- H.J. Heinz Company
- Hospira Inc.
- Groupe Danone
- Fresenius Kabi AG
- Baxter International Inc.
- Nestle SA
Segments Covered in the Report
By Route of Administration
- Oral
- Enteral
- Parental
By Application
- Cancer
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
By End User
- Pediatric
- Adult
- Geriatric
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Clinical Nutrition Market
5.1. COVID-19 Landscape: Clinical Nutrition Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Clinical Nutrition Market, By Route of Administration
8.1. Clinical Nutrition Market, by Route of Administration Type, 2021-2030
8.1.1. Oral
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Enteral
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Parental
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Clinical Nutrition Market, By Application
9.1. Clinical Nutrition Market, by Application, 2021-2030
9.1.1. Cancer
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Metabolic Disorders
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Gastrointestinal Disorders
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Neurological Disorders
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Clinical Nutrition Market, By End User
10.1. Clinical Nutrition Market, by End User, 2021-2030
10.1.1. Pediatric
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Adult
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Geriatric
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Clinical Nutrition Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Route of Administration (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. B. Braun Melsungen AG.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Mead Johnson Nutrition Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Perrigo Company Plc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. H.J. Heinz Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Hospira Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Groupe Danone
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Fresenius Kabi AG
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Baxter International Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Nestle SA
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global clinical nutrition market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for clinical nutrition are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1527
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
